Patrik Jeanmonod, Chief Financial Officer at Cytek Biosciences, Inc. (CTKB), sold 3,000 shares at $6.38 ($19K) on 2023-09-25, disclosed to the SEC on 2023-09-26.
Scheduled sale ($19k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTKB | SELL | 2023-10-25 | $14K | — | Filing → |
| CTKB | SELL | 2023-08-28 | $23K | — | Filing → |
| CTKB | SELL | 2023-07-25 | $28K | — | Filing → |